The modified exendin (Exendins) and its use

The present invention, in the amino acid sequence of an insulin secretagogue peptide, second, 14 th, 27 th, about 28-th one or more positions modified exendin-4 and polyethylene glycol derivatives in the. These compounds as agonists of GLP-1) receptor, is used to treat type II diabetes.